Form EFFECT Medicus Pharma Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 27, 2026 |
| Accession Number: | 0001062993-26-001619 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
- Come See One of Country's Fastest-Rising Artists, Jovi Greene, Make His Canadian Debut at Toronto's Horseshoe Tavern August 4 at 8 PM
- Vassal Benford’s Historic Role in the $1.2 Billion Kings’ Crossing Bridge Project Vassal Benford Makes History with the Kings’ Crossing Bridge, a Landmark American Infrastructure Project
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
